| Literature DB >> 33882966 |
Qudsia Uzma1, Nausheen Hamid2, Rizwana Chaudhri3, Nadeem Mehmood4, Atiya Aabroo5, Ellen Thom6, Karima Gholbzouri7, Ramez Mahaini8, Nilmini Hemachandra9.
Abstract
BACKGROUND: Pakistan is among a number of countries facing protracted challenges in addressing maternal mortality with a concomitant weak healthcare system complexed with inequities. Sexual and reproductive health and rights (SRHR) self-care interventions offer the best solution for improving access to quality healthcare services with efficiency and economy. This manuscript documents country experience in introducing and scaling up two selected SRHR self-care interventions. A prospective qualitative study design was used and a semi-structured questionnaire was shared with identified SRHR private sector partners selected through convenience and purposive sampling. The two interventions include the use of misoprostol for postpartum hemorrhage and the use of subcutaneous depomedroxyprogesterone acetate (DMPA) as injectable contraceptive method. Data collection was done through emails and telephone follow-up calls.Entities:
Year: 2021 PMID: 33882966 PMCID: PMC8058573 DOI: 10.1186/s12961-021-00714-0
Source DB: PubMed Journal: Health Res Policy Syst ISSN: 1478-4505
Fig. 1Conceptual framework for exploring partner’s contribution to sexual and reproductive health and rights (SRHR) self-care experiences
Organizational profiles related to sexual and reproductive health and rights programmes
| Respondent number | Experience with misoprostol or SC DMPA? | Organization’s profile related to SRHR programming in Pakistan | ||||||
|---|---|---|---|---|---|---|---|---|
| Policy advocacy for SRHR services | Technical support for guidelines/ training modules/ reporting tools etc | Training of trainers | Cascade training | Training follow ups | Implementation in field | Supervision and monitoring | ||
| 1 | Misoprostol | √ | √ | √ | √ | √ | √ | √ |
| 2 | SC DMPA | √ | √ | √ | √ | √ | √ | √ |
| 3 | Misoprostol | √ | √ | √ | ||||
| 4 | Misoprostol | √ | √ | √ | √ | √ | √ | |
| 5 | Misoprostol | √ | √ | √ | √ | √ | √ | √ |
| 6 | Misoprostol | √ | √ | √ | √ | √ | √ | |
| 7 | Both | √ | √ | √ | √ | √ | √ | √ |
| 8 | Both | √ | √ | √ | √ | √ | √ | √ |
| 9 | SC DMPA | √ | √ | |||||
DMPA Depomedroxyprogesterone acetate, SC subcutaneous, SRHR sexual and reproductive health and rights
Fig. 2Training approach adopted by SRHR partners who shared their self-care experience
Fig. 3Duration of training sessions on selected two SRHR self-care interventions. SC DMPA Subcutaneous depomedroxyprogesterone acetate
Number of trainings and providers trained by partners on self-care SRHR interventions
| Respondent number | Conducted trainings on self-care? (yes/no) | Estimated number of training sessions to date | Estimated number of providers trained | Duration of training | Training implemented as: | |
|---|---|---|---|---|---|---|
| Separate session | Integrated with SRHR | |||||
| 1 | Yes | 17 | 1980 | 5 days | √ | √ |
| 2 | Yes | > 40 | 666 | 1 day | √ | – |
| 3 | No | – | – | – | – | – |
| 4 | Yes | > 60 | 1900 | 30 min to 0.5 day | – | √ |
| 5 | Yes | 2 | 50 | 0.5 day | – | √ |
| 6 | Yes | > 400 | > 1000 | 0.5–1 day | √ | √ |
| 7 | Yes | 8 | 75 | 1 day | – | √ |
| 8 | Yes | 116 | > 100 | 5–6 days | – | √ |
| 9 | No | 1 | 30 | 2 days | √ | – |
Types of cadres trained by SRHR partners who shared their self-care experience
| Respondent number | Trained on both self-care interventions (misoprostol and SC DMPA) | Trained on use of SC DMPA | Trained on use of misoprostol | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Medical doctors | Nurses | Midwives | Lady health visitors | Counsellors | Family welfare workers | Project staff | Community volunteers | Programme managers | |
| 1 | √ | √ | √ | √ | – | √ | √ | – | √ |
| 2 | √ | √ | √ | √ | √ | √ | – | – | √ |
| 3 | – | – | – | – | – | – | – | – | – |
| 4 | √ | √ | √ | √ | √ | √ | – | – | √ |
| 5 | √ | √ | √ | √ | √ | √ | – | – | – |
| 6 | √ | √ | √ | √ | √ | √ | √ | √ | – |
| 7 | – | √ | √ | √ | – | – | – | – | √ |
| 8 | √ | – | √ | √ | – | √ | √ | – | √ |
| 9 | √ | – | √ | √ | √ | – | – | – | – |